Centene Corporation Reports 2013 Second Quarter Earnings of $0.70 Per Diluted Share Including $0.07 of AcariaHealth Transaction Costs
7/23/2013 6:24:14 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
ST. LOUIS, July 23, 2013 /PRNewswire/ -- Centene Corporation CNC today announced its financial results for the quarter ended June 30, 2013.
Premium and Service Revenues (in millions)
Consolidated Health Benefits Ratio
comments powered by